{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:23Z","timestamp":1787729423914,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T00:00:00Z","timestamp":1616803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["Z01 DE000649"],"award-info":[{"award-number":["Z01 DE000649"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00198-021-05895-6","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T01:02:34Z","timestamp":1616806954000},"page":"1889-1893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects"],"prefix":"10.1007","volume":"32","author":[{"given":"L.N.","family":"Raborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.","family":"Ebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.B.","family":"Kaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-3887","authenticated-orcid":false,"given":"A.M.","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,27]]},"reference":[{"key":"5895_CR1","doi-asserted-by":"publisher","unstructured":"Boyce AM, Collins MT (2020) Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of G\u03b1 s activation. Endocr Rev 41(2):345\u201370. https:\/\/doi.org\/10.1210\/endrev\/bnz011","DOI":"10.1210\/endrev\/bnz011"},{"key":"5895_CR2","unstructured":"Boyce AM, Florenzano P, de Castro LF, Collins MT (1993) Fibrous dysplasia\/McCune-Albright syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews\u00ae, Seattle (WA): University of Washington, Seattle; 1993\u20132021. PMID: 25719192"},{"issue":"4","key":"5895_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/17453674.2019.1608117","volume":"90","author":"BCJ Majoor","year":"2019","unstructured":"Majoor BCJ, Traunmueller E, Maurer-Ertl W, Appelman-Dijkstra NM, Fink A, Liegl B, Hamdy NAT, Sander Dijkstra PD, Leithner A (2019) Pain in fibrous dysplasia: relationship with anatomical and clinical features. Acta Orthop 90(4):401\u2013405","journal-title":"Acta Orthop"},{"issue":"6","key":"5895_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/odi.12563","volume":"23","author":"AB Burke","year":"2017","unstructured":"Burke AB, Collins MT, Boyce AM (2017) Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis 23(6):697\u2013708","journal-title":"Oral Dis"},{"issue":"1","key":"5895_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","volume":"14","author":"MK Javaid","year":"2019","unstructured":"Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT (2019) Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium. Orphanet J Rare Dis 14(1):139","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"5895_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2106\/JBJS.O.00547","volume":"98","author":"AI Leet","year":"2016","unstructured":"Leet AI, Boyce AM, Ibrahim KA, Wientroub S, Kushner H, Collins MT (2016) Bone-grafting in polyostotic fibrous dysplasia. J Bone Joint Surg Am 98(3):211\u2013219","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"5895_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jbmr.3649","volume":"34","author":"P Florenzano","year":"2019","unstructured":"Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, de Castro LF, Collins MT, Boyce AM (2019) Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res 34(4):653\u2013660","journal-title":"J Bone Miner Res"},{"issue":"10","key":"5895_CR8","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1210\/jc.2003-030050","volume":"88","author":"H Plotkin","year":"2003","unstructured":"Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH (2003) Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J Clin Endocrinol Metab 88(10):4569\u20134575","journal-title":"J Clin Endocrinol Metab"},{"key":"5895_CR9","doi-asserted-by":"publisher","unstructured":"van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H (2020) Current concepts in the treatment of giant cell tumour of bone. Curr Opin Oncol 32(4):332\u2013338. https:\/\/doi.org\/10.1097\/CCO.0000000000000645","DOI":"10.1097\/CCO.0000000000000645"},{"issue":"2","key":"5895_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jbmr.3602","volume":"34","author":"LF de Castro","year":"2019","unstructured":"de Castro LF, Burke AB, Wang HD, Tsai J, Florenzano P, Pan KS, Bhattacharyya N, Boyce AM, Gafni RI, Molinolo AA, Robey PG, Collins MT (2019) Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden. J Bone Miner Res 34(2):290\u2013294","journal-title":"J Bone Miner Res"},{"issue":"12","key":"5895_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/jbmr.3828","volume":"34","author":"B Palmisano","year":"2019","unstructured":"Palmisano B, Spica E, Remoli C, Labella R, Di Filippo A, Donsante S, Bini F, Raimondo D, Marinozzi F, Boyde A et al (2019) RANKL inhibition in fibrous dysplasia of bone: a preclinical study in a mouse model of the human disease. J Bone Miner Res 34(12):2171\u20132182","journal-title":"J Bone Miner Res"},{"issue":"4","key":"5895_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","volume":"15","author":"AM Boyce","year":"2017","unstructured":"Boyce AM (2017) Denosumab: an emerging therapy in pediatric bone disorders. Curr Osteoporos Rep 15(4):283\u2013292","journal-title":"Curr Osteoporos Rep"},{"key":"5895_CR13","unstructured":"https:\/\/libguides.pcom.edu\/icmje\/package_inserts"},{"issue":"7","key":"5895_CR14","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/jbmr.1603","volume":"27","author":"AM Boyce","year":"2012","unstructured":"Boyce AM, Chong WH, Yao J, Gafni RI, Kelly MH, Chamberlain CE, Bassim C, Cherman N, Ellsworth M, Kasa-Vubu JZ, Farley FA, Molinolo AA, Bhattacharyya N, Collins MT (2012) Denosumab treatment for fibrous dysplasia. J Bone Miner Res 27(7):1462\u20131470","journal-title":"J Bone Miner Res"},{"issue":"3","key":"5895_CR15","first-page":"253","volume":"13","author":"C Eller-Vainicher","year":"2016","unstructured":"Eller-Vainicher C, Rossi DS, Guglielmi G, Beltramini GA, Cairoli E, Russillo A, Mantovani G, Spada A, Chiodini I (2016) Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia. Clin Cases Miner Bone Metab 13(3):253\u2013256","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"12","key":"5895_CR16","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1210\/jc.2018-02543","volume":"104","author":"BCJ Majoor","year":"2019","unstructured":"Majoor BCJ, Papapoulos SE, Dijkstra PDS, Fiocco M, Hamdy NAT, Appelman-Dijkstra NM (2019) Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates. J Clin Endocrinol Metab 104(12):6069\u20136078","journal-title":"J Clin Endocrinol Metab"},{"key":"5895_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","volume":"105","author":"E Tsourdi","year":"2017","unstructured":"Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Gua\u00f1abens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC (2017) Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone. 105:11\u201317","journal-title":"Bone."},{"issue":"9","key":"5895_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00256-020-03449-1","volume":"49","author":"K van Langevelde","year":"2020","unstructured":"van Langevelde K, McCarthy CL (2020) Radiological findings of denosumab treatment for giant cell tumours of bone. Skelet Radiol 49(9):1345\u20131358","journal-title":"Skelet Radiol"},{"issue":"3","key":"5895_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","volume":"69","author":"I Girolami","year":"2016","unstructured":"Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A (2016) Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series. J Clin Pathol 69(3):240\u2013247","journal-title":"J Clin Pathol"},{"issue":"9","key":"5895_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/jbmr.3738","volume":"34","author":"GZ Papadakis","year":"2019","unstructured":"Papadakis GZ, Manikis GC, Karantanas AH, Florenzano P, Bagci U, Marias K, Collins MT, Boyce AM (2019) (18) F-NaF PET\/CT imaging in fibrous dysplasia of bone. J Bone Miner Res 34(9):1619\u20131631","journal-title":"J Bone Miner Res"},{"issue":"6","key":"5895_CR21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00259-019-04657-1","volume":"47","author":"W van der Bruggen","year":"2020","unstructured":"van der Bruggen W, Hagelstein-Rotman M, de Geus-Oei LF, Smit F, Dijkstra PDS, Appelman-Dijkstra NM, Vriens D (2020) Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET\/CT. Eur J Nucl Med Mol Imaging 47(6):1527\u20131537","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"5895_CR22","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1359\/jbmr.080609","volume":"23","author":"SA Kuznetsov","year":"2008","unstructured":"Kuznetsov SA, Cherman N, Riminucci M, Collins MT, Robey PG, Bianco P (2008) Age-dependent demise of GNAS-mutated skeletal stem cells and \u201cnormalization\u201d of fibrous dysplasia of bone. J Bone Miner Res 23(11):1731\u20131740","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-05895-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T06:08:47Z","timestamp":1629871727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-05895-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,27]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5895"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-05895-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,27]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient in this study was seen as part of a natural history study approved by the Investigational Review Board of the NIDCR, NIH (NCT00001727). Informed assent and consent were obtained from the patient and her guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"NIDCR receives support from Amgen, Inc for an investigator-sponsored study of denosumab for fibrous dysplasia (Alison Boyce, Michael Collins). Layne Raborn, Andrea Burke, David Ebb, and Leonard Kaban report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}